Safety Considerations for Product Design to Minimize Medication Errors Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 12, 2016
April 24, 2020
8237a0b9-a53f-4a27-a231-874107d935de
Related Documents
Botanical Drug Development: Guidance for Industry
Guidance DocumentDecember 29, 2016Center for Drug Evaluation and Research
Immunogenicity-Related Considerations for Low Molecular Weight Heparin Guidance for Industry
Guidance DocumentFebruary 18, 2016Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
Guidance DocumentSeptember 26, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox